The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.
Moniot A, Schneider C, Chardin L, Yaniz-Galende E, Genestie C, Etiennot M, Henry A, Drelon C, Le Formal A, Langlois B, Venat L, Louvet C, Favier L, Lortholary A, Berton-Rigaud D, Dohollou N, Desauw C, Fabbro M, Malaurie E, Dubot C, Kurtz JE, Bonichon Lamichhane N, Pujade-Lauraine É, Jeanne A, Leary A, Dedieu S.
Moniot A, et al. Among authors: yaniz galende e.
Mol Cancer. 2024 Aug 14;23(1):166. doi: 10.1186/s12943-024-02073-0.
Mol Cancer. 2024.
PMID: 39138571
Free PMC article.